Learn More
Apexbio Technology LLC γDGG 6729-55-1 50mg

Supplier: Apexbio Technology LLC B620950
DGG (CAS 6729-55-1) is a competitive antagonist selective for AMPA-type glutamate receptors where it inhibits excitatory synaptic transmission through direct receptor binding Experimental studies demonstrate that DGG decreases neuronal activity and modulates multiple signaling pathways within the central nervous system Owing to its defined mechanism of action DGG serves as a valuable tool in the investigation of glutamatergic neurotransmission and is broadly utilized in neuroscience research including studies related to central nervous system disorders
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.